Fuel-independent and membrane-less self-charging biosupercapacitor
We present a fuel-independent self-charging biosupercapacitor comprising an oxygen reducing enzymatic biocathode and an opposing bioelectrode, in which the supercapacitive properties of immobilised protein were utilised. Our findings disclose a novel hybrid type of bioelectrochemical systems, which can potentially be employed as autonomous power suppliers in substratedeficient conditions.
The rapidly differentiating field of portable and autonomous miniature electronics operating under ex vivo and in vivo conditions requires power sources capable of efficient operation in close contact with physiological fluids or inside the human body. Enzymatic fuel cells (EFCs) are bioelectrochemical devices, which directly convert chemical energy into electric power, while fuel and oxidant are continuously supplied to the electrodes. As distinct from the conventional fuel cells, where employment of abiotic catalysts usually requires harsh environment for efficient operation (e.g. strong acidic or basic media, high temperature), EFCs are capable to function at human physiological pH and temperature. EFCs utilize enzymes (oxidoreductases) to facilitate oxidation or/and reduction reactions occurring on the bioanode and biocathode, respectively. These miniature power sources enable delivering power densities up to several mW cm -2 1 and attract specific attention as autonomous power suppliers for implantable or disposable medical devices for monitoring of diseases during short periods up to several months. 2 The performance of EFCs was examined in vivo in rats, 3 rabbits 4-5 and ex vivo in human blood, 6 demonstrating the perspectives of their practical application.
In spite of all possible advantages of EFCs, they cannot be efficiently applied, when the concentration of oxidant or/and fuel is not sufficient to provide satisfactory power output or performance of the electrode is underachieved to establish the necessary level of chemical energy conversion. Several strategies have been proposed to overcome these restrictions.
Switching from continuous to intermittent mode in supercapacitive EFCs allows accumulation of charge during long-term low-power operation, which can be instantaneously extracted in short high-power pulses. [7] [8] Another approach is related to the development of hybrid devices, where a lowperformance bioelectrode can be replaced with a rechargeable battery-type or pseudocapacitive abiotic electrodes based on Prussian Blue, 9 Ag 2 O/Ag 10 or MnO 2 11 for the cathodic side.
However, any practical long-term applicability of inorganic materials in implantable conditions is debatable due to the inflammatory response and possible poisoning with leaking heavy metal ions. Recently a novel concept, denoted proteinbased biosupercapacitors (BSCs), has been demonstrated by Mosa et al., 12 where different protein films were layer-by-layer assembled with reduced graphene oxide. Biomodification with protein leads to a significant enhancement of the electrode capacitance due to adsorption/desorption of electrolyte ions and protonation/deprotonation of the amino acid side chains. The potential employment of surface-confined acid/base reactions of organic molecules for charge-storing purposes has also been recently demonstrated. 13 Since the processes determining the charge-storing features of immobilised protein molecules are reversible, one can expect the recovery of the electrical double layer structure after the discharging pulse, i.e. so-called self-charging behavior, previously reported for enzyme-based electrodes, rapidly recharging after current pulses or when an external load was applied. Please do not adjust margins
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In this work, we aimed to develop a self-charging bioelectrode based on the supercapacitive properties of myoglobin (Mb) immobilised on the surface of functionalised gold nanoparticles (AuNPs) to substitute a fuel-dependent bioanode in a conventional charge-storing EFC operating in a pulse mode for potential application under implantable or wearable conditions. Mb has a significant ratio of charged residue/molar mass, which determines a higher capacitance of Mb-based electrodes compared to bioelectrodes based on hemoglobin, cytochrome c, glucose oxidase and catalase. 12 Being a neutral protein with an isoelectric point close to 7.0, 14 Mb has an overall negative charge at pH 7.5. To create the very first example of a hybrid bioelectrochemical device, combining energy-converting and electrostatic supercapacitive rechargeable bioelectrodes, an Mb/AuNPs electrode has been further coupled with a biocathode based on bilirubin oxidase (BOx), inversely charged due to oxygen reducing activity of immobilised enzyme. AuNPs with an average size of 9.2 (NP 9 ) and of 35.9 nm (NP 36 ) determined by atomic force microscopy ( Fig. S1 , ESI †) were prepared by the common citrate-reduction procedure. Asprepared NP 9 were electrostatically coated with polycations polyethyleneimine (NP (+) ) or poly(allylamine hydrochloride) with a subsequent coverage with polyanion poly(sodium 4styrenesulfonate) (NP (-) ) to obtain a positively or a negatively charged surface in neutral media following previously reported protocols. 15 Detailed description of the experimental procedures is provided in the Supporting Information. Mb was immobilised on glassy carbon electrodes modified with NP (-) or NP (+) to create diverse surface charges for suitable protein orientation. Both NP (-) to Mb-modified graphene electrodes, 12 azurin-modified Au(111) electrodes 16 and some inorganic materials, such as RuO 2 or MnO 2 . 17 To assemble a fuel-independent membrane-less self-charging biosupercapacitor (SCBSC), a Mb-modified NP (-) bioelectrode (Mb/NP (-) ) possessing no anodic bioelectrocatalytic ability ( Fig.  S3 , ESI †) was combined with an oxygen-reducing biocathode based on BOx, adsorbed on a highly developed threedimensional gold matrix (Fig. 1D ) of NP 36 treated in 0.5 M sulfuric acid (Scheme 1). Since the capacitance of the biocathode was 4.8-fold higher than that for the Mb-modified NP (-) electrode (Fig. 1C) , the charge-storing ability of the hybrid biodevice was limited by the Mb/NP (-) . Utilization of threedimensional BOx/AuNPs biocathodes for bioelectrocatalytic oxygen reduction has been well established in recent works related to supercapacitive enzymatic fuel cells 18 and biosolar cells 19 24 The stabilised SCBSC was discharged by applying a current pulse of 10 µA cm -2 for 1 s, which leads to a voltage drop of 0.19 ± 0.02 V, which remains constant for at least 20 following cycles of continuous charge/discharge operation. The overall capacitance of the SCBCS calculated from fast galvanostatic discharge was 25% lower than the expected value considering the capacitance of the separate bioelectrodes calculated from CVs, following a common antithetical correlation between the capacitance and scan (or discharge) rate for pseudocapacitive materials. 25 An average peak power output of ca. 3 µW cm -2 achieved for the fuel-independent membrane-less SCBSC is similar to that for lactate/oxygen EFCs [26] [27] and glucose/oxygen EFCs designed for operation at low concentrations of fuel. [28] [29] The self-recharging process was carried out for 900 ± 30 s after the pulse was applied and led to a 91%, 98% and 99% recovery of the OCV after the 1 st , 10 th and 20 th discharging pulses, respectively, indicating a dynamic stabilization of the performance of the SCBCS on an OCV of ca. 0.24 V (Fig. 2) . This OCV value obtained for the fuel-independent SCBCS is twice as high as the value achieved in a recent report in the presence of glucose, 24 demonstrating the advantages of the proposed concept over conventional EFCs adapted to operate in the pulse mode.
Taking into account that a low potential drop during the discharging process and the oxygen reducing activity determine the rapid recovery of the OCP of the cathode, the self-recharging ability and stability of the assembled SCBSC are mainly determined by the Mb/NP (-) (Fig. 2B) . Since there were no significant changes in the capacitance, this suggests that no Mb desorption occurred during the experiments, but rather a gradual flattening and compression of the enzyme layer could be considered as the origin of the decrease in the OCV value (and growth of OCP of the Mb/NP (-) ), similarly to the effect demonstrated for the biocathodes based on BOx physisorbed on the Au surface. 30 The design of a supercapacitive protein electrode based on a sub-monolayer coverage with AuNPs can easily be adapted to create transparent electrodes to substitute enzymatic bioanodes for potential utilization without any significant losses in transparency ( Fig. S4, ESI †) , in contrast to reported analogues. 24, [26] [27] Taking into account the concept of a self-rechargeable protein electrode and the fuel-independent SCBCS presented herein, it should be emphasised that classification of biosupercapacitors into conventional and self-charging based on their operational principles 8 cannot be justified. Even the so-termed conventional BSCs possess complete or a particular ability to recover their surface charge in solution not only due to "active" enzymatic energy conversion ability, but also because of "passive" electrostatic equilibration, therefore classification of biological power sources to energy converting, charge storing and hybrid devices looks more reasonable, taking into account recent progress in the field. Energy converting systems, viz. conventional and supercapacitive EFCs, photobioelectrochemical cells, are designed for irreversible conversion of light or chemical energy into electric power and require substrates for operation, charge-storing BSCs and biobatteries employ electrostatic, pseudocapacitive or faradaic properties of immobilised biomaterials for reversible chargestoring purposes, whereas hybrid devices combine electrodes of different types, such as the SCBCS presented in this work.
In conclusion, the present study has revealed a novel concept of a fuel-independent and membrane-less self-charging biosupercapacitor, combining an enzymatic biocathode employing the oxygen-reducing activity of BOx and a protein electrode gaining the advantages of the pseudocapacitive properties of immobilised Mb. The characteristics of the SCBCS achieved in pulse mode together with a notable operational stability compared to recently reported analogues, allow to consider this kind of hybrid biological power source as a possible alternative to conventional and supercapacitive EFCs, which require substrates for active charging of enzymatic electrodes. The findings reported herein may be a significant step towards development of more efficient and biocompatible biological power sources and self-powered biosensors intermittently operating in physiological fluids under lack of fuel, e.g. in tears or saliva. 31 
